KR101576709B1 - Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments - Google Patents
Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments Download PDFInfo
- Publication number
- KR101576709B1 KR101576709B1 KR1020130070660A KR20130070660A KR101576709B1 KR 101576709 B1 KR101576709 B1 KR 101576709B1 KR 1020130070660 A KR1020130070660 A KR 1020130070660A KR 20130070660 A KR20130070660 A KR 20130070660A KR 101576709 B1 KR101576709 B1 KR 101576709B1
- Authority
- KR
- South Korea
- Prior art keywords
- nucleic acid
- acid fragments
- chamber
- sequencing
- sequence
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Abstract
(a) preparing a sequencing plate having a DNA library; (b) providing a scaled down nucleic acid fragment library sequenced through hyperparallel sequencing of said DNA library; (c) positioning the sequencing plate with all of the sequence-identified nucleic acid fragments in an amplifier; (d) amplifying the entire nucleic acid fragments located in the amplifier; And (e) recovering the amplified nucleic acid fragments.
Description
The techniques disclosed herein relate to methods for recovering nucleic acid fragments whose sequences have been identified after sequence sequencing analysis, and also to a sealing chamber for performing such a method.
As biotechnology advances, the importance of high-speed, superparallel DNA synthesis and analysis technology is also growing. In the 20th century, the development of next-generation sequencing has led to ultra-fast, superparallel DNA analysis. Along with the development of new analytical methods, we have made remarkable progress in reducing the time required for analysis and increasing the amount of data that can be analyzed. Currently, next-generation base analysis methods such as Illumina, Roche-454, and Ion-Torrent analyze the base sequence based on the chemical reactions occurring at each site by connecting the DNA libraries to be analyzed on the solid phase. Recently, as gene synthesis technology has been developed and its application range has been increased, the development of super fast and super parallel gene synthesis technology is also increasing in importance. A prerequisite for super-parallel gene synthesis is the synthesis of gene libraries. Conventional gene synthesis methods have limitations on the synthesis of ultra-fast and superparallel sequences of gene libraries, but using the recently developed 'shotgun DNA synthesis' method, it has become possible to synthesize gene libraries.
Previously, nucleic acid fragments analyzed by the next-generation base analysis method were only able to acquire the nucleotide sequence information, and it was very difficult to recover the nucleic acid fragments themselves. Recently, after the next-generation base analysis, Was developed. The first method is to map the information of each well of the assay plate and the analyzed base sequence information after the next generation base analysis and to pick up the bead to which the desired nucleic acid fragment remaining on the plate is connected, (High-fidelity gene synthesis by retrieval of sequence-verified DNA identified using high-throughput pyrosequencing, 2010 Nature Biotechnology, Mark Matzas et al). The second method involves linking the barcode sequence to a DNA library obtained from an organism or artificially synthesized, and analyzing a portion of the DNA pool using next-generation sequencing ('Shotgun DNA synthesis' for the high-throughput construction of large DNA molecules, 2012 Nucleic Acids Research, Kim et al). Then, the desired nucleic acid fragment is selectively amplified from the remaining DNA pool using a primer containing a bar code sequence. These methods have the advantage of being able to selectively recover the nucleic acid fragments for which the nucleotide sequence has been confirmed using the next generation sequencing method.
However, the method of picking the bead has the disadvantage of requiring expensive equipment for bead picking. In addition, the method of recovering a nucleic acid fragment using a barcode sequence has a limitation in recovering a desired nucleic acid fragment because of the size of the large DNA library when a population of artificially synthesized DNA library obtained from an organism is very large . For example, if hundreds of genes are synthesized at the same time, the pool will contain hundreds of millions to tens of millions of kinds of nucleic acid fragments, regardless of whether they are errors or not. Selective amplification of only one type of nucleic acid fragment desired by the experimenter from this pool is considerably difficult due to the large size of the library and the recovery rate is also low.
It is an object of the present invention to provide a method for easily recovering nucleic acid fragments that have been identified from a whole DNA library.
It is another object of the present invention to provide a sealing chamber for recovering sequence-recognizing nucleic acid fragments.
According to one aspect of the present invention, there is provided a method of detecting nucleic acid, comprising: (a) positioning nucleic acid fragments identified by sequencing in an amplifier; (b) amplifying the sequence-confirmed nucleic acid fragments; And (c) recovering the amplified nucleic acid fragments.
According to another aspect of the present invention there is provided a method of amplifying nucleic acid comprising: (a) connecting an adapter sequence to nucleic acid fragments before sequencing; (b) sequencing nucleic acid fragments to which said adapter is attached; (c) positioning said sequence-identified nucleic acid fragments in an amplifier; (d) amplifying the sequence-confirmed nucleic acid fragments; And (e) recovering the amplified nucleic acid fragments.
According to another aspect of the present invention, there is provided a method for preparing a DNA library, comprising: (a) preparing a sequencing plate having a DNA library; (b) providing a scaled down nucleic acid fragment library sequenced through hyperparallel sequencing of said DNA library; (c) positioning the sequencing plate with all of the sequence-identified nucleic acid fragments in an amplifier; (d) amplifying the entire nucleic acid fragments located in the amplifier; And (e) recovering the amplified nucleic acid fragments.
According to another aspect of the present invention, there is provided a sealing chamber for amplifying nucleic acid fragments, comprising: a base chamber capable of receiving a sequencing plate having nucleic acid fragments; An upper chamber which is engageable with and detachable from the base chamber and has a sealing structure as a whole when engaged with the base chamber; And an elastic gasket disposed between the base chamber and the upper chamber for sealing, wherein an inner space for accommodating the PCR solution for amplifying the nucleic acid fragments is formed by the coupling of the base chamber and the upper chamber , At least one of the base chamber and the upper chamber is provided with a sealing chamber made of a material having thermal conductivity.
According to another aspect of the present invention, there is provided a sealing chamber for amplifying nucleic acid fragments, comprising: a base chamber having a storage chamber; An upper chamber disposed on the base chamber; A sample accommodating portion accommodated in the accommodating chamber and having a receiving space for accommodating a sample for amplifying the nucleic acid fragments; A gasket disposed between the base chamber and the upper chamber and having elasticity; A jig having a threaded hole connected to the base chamber and extending to an upper portion of the upper chamber, the threaded hole having an internally threaded portion; And a pressing portion that is screwed to the screw hole, wherein the pressing portion includes a screw portion having a male screw portion, and a head disposed on the screw portion, wherein a displacement of the pressing portion with respect to the jig A sealing chamber is provided in which pressing of the upper chamber by the pressing portion is achieved.
In the method of amplifying nucleic acid fragments after sequencing of the present invention, the DNA library to be amplified can be shrunk to remarkably increase the recovery rate of a desired nucleic acid fragment. That is, if the size of the DNA library is very large, the recovery rate of the desired nucleic acid fragment is low because of the complexity of the DNA library. Accordingly, shrinking the DNA library using the present invention can reduce the complexity of the DNA library and increase the recovery rate of the desired nucleic acid fragment. Further, although a method of utilizing conventional sequence-confirmed nucleic acid fragments has been limited, it has been efficiently improved to increase utilization of nucleic acid fragments that have been identified.
In addition, according to the sealing chamber of the present invention, a base chamber capable of accommodating a sequencing plate having sequence-identified nucleic acid fragments can be combined with and detachable from the base chamber, and has an overall sealing structure when the base chamber is combined with the base chamber. An inner space in which a PCR solution for amplifying the nucleic acid fragments is accommodated is formed by the combination of the base chamber and the upper chamber, and an elastic gasket disposed between the base chamber and the upper chamber for sealing, It is possible to effectively prevent foreign substances or the like from penetrating into the sample. Further, as the pressurizing piece is provided in the upper chamber, damage to the upper chamber can be prevented, and maintenance, maintenance, and management can be easily performed only by replacing the pressure piece. In addition, since the gasket, the upper chamber, and the base chamber are formed with predetermined concavities and convexities, the infiltration path of the foreign matter is extended, so that foreign matter penetration can be more effectively blocked.
Figure 1 shows a flow chart of a method for recovering sequenced nucleic acid fragments through sequencing.
Figure 2 shows the recovered product of nucleic acid fragments sequenced through sequencing.
Figure 3 shows individual nucleic acid fragments amplified using selective amplification primers using the recovered products of nucleic acid fragments identified by sequencing.
FIG. 4 shows the nucleotide sequence analysis results of Sanger sequencing of selectively amplified individual nucleic acid fragments.
5 is a perspective view of a sealing chamber according to an embodiment of the present invention.
6 shows an exploded view of a sealing chamber according to an embodiment of the present invention.
7 shows a top view of a sealing chamber according to an embodiment of the invention.
Figure 8 shows a cross-sectional view along AA of Figure 7;
9 is a cross-sectional view taken along the line BB of Fig.
Hereinafter, various embodiments of the present invention will be described in detail.
In order to overcome the limitations of the bead picking method or the method of recovering nucleic acid fragments using the bar code sequence as described above, the present inventors have effectively reduced the DNA library to alleviate the restriction by the size of the DNA library, A method and an apparatus capable of recovering the entire nucleic acid fragments analyzed without loss have been developed and the present invention has been completed.
According to an embodiment of the present invention, there is provided a method of amplifying nucleic acid comprising: (a) locating nucleic acid fragments identified by sequencing in an amplifier; (b) amplifying the sequence-confirmed nucleic acid fragments; And (c) recovering the amplified nucleic acid fragments.
In one embodiment, prior to sequencing the nucleic acid fragments to be sequenced, an adapter sequence may be coupled to the nucleic acid fragments to be sequenced prior to sequencing, and sequencing of the nucleic acid fragments to which the adapter is coupled.
Specifically, first, the sequence-identified nucleic acid fragments are placed in an amplifier.
The sequencing may be performed by a method of synthesizing nucleic acid fragments. In this case, the nucleic acid fragment may be synthesized by a Sanger method or a hyperparallel method (Michael L. Metzker, Nature Reviews, Vol. II, 2010 January, 'Seqeuencing technologies-the next generation'). Here, the hyperparallel method may be a method such as pyrosequencing chemistry, bridge amplification, next generation sequencing, third generation sequencing, next generation sequencing, or semiconductor sequencing, but is not limited thereto.
If the length of the nucleic acid fragment to be sequenced is longer than the length of the nucleic acid fragment proposed in the next generation sequencing method to be used, it can be fragmented using a restriction enzyme method or a physical shearing method. When the length of the nucleic acid fragment is short, it is possible to extend the length using a method such as assemble or ligation.
In addition, the amplifier may be a sealed chamber in which a predetermined sample is received and sealed. Said sealing chamber for amplifying nucleic acid fragments comprises: a base chamber capable of containing a sequencing plate with said nucleic acid fragments; An upper chamber which is engageable with and detachable from the base chamber and has a sealing structure as a whole when engaged with the base chamber; And an elastic gasket disposed between the base chamber and the upper chamber for sealing. At this time, the inner space in which the PCR solution for amplifying the nucleic acid fragments is accommodated is formed by the coupling of the base chamber and the upper chamber. At least one of the base chamber and the upper chamber is made of a thermally conductive material so that the temperature of the internal PCR solution can be easily adjusted according to temperature control of the water tank when the sealing chamber is immersed in the water tank.
An embodiment of the sealing chamber is shown in Fig. 5, the
In addition, when the sequence-confirmed nucleic acid fragments are placed in the amplifier, the sequencing plate in which the sequence-confirmed nucleic acid fragments are present can be placed in the amplifier after the completion of the sequence check. That is, the recovered plate for next-generation nucleotide sequencing can be mounted and sealed in the sealed chamber. When placing the sequence-identified nucleic acid fragments in the amplifier, the whole plate is placed in the amplifier in the sequenced state without cutting off the filler portion of the sequencing plate or separately separating the nucleic acid fragments identified in the plate.
Next, the nucleic acid fragments that have been identified are amplified.
Injecting a DNA polymerase, a dNTP, a primer, a buffer, and / or a PCR solution into the sequence-identified nucleic acid fragments for amplification of the sequence-identified nucleic acid fragments. The DNA polymerase may be, but is not limited to, Tag polymerase, Pfu polymerase, and the like.
The next amplified nucleic acid fragments are recovered. For example, a PCR solution and amplified nucleic acid fragments can be recovered using a pipette. With this method, the entire nucleic acid fragment whose nucleotide sequence has been identified can be recovered without loss.
Next, desired nucleic acid fragments of the recovered nucleic acid fragments are recovered. As a method of recovering the desired nucleic acid fragments, a conventional method for recovering nucleic acid fragments can be used. A kit for recovering nucleic acid fragments sold on the market or a method using the kit may be applied. In addition, if the amplified nucleic acid fragments are bound to beads or have a specific bar code sequence connected thereto, the nucleic acid fragments can be recovered using a bead recovery or a sequence homologous to the bar code sequence.
Amplification of sequence-identified nucleic acid fragments can be amplified or extended using a temperature-controllable instrument such as an oven or water bath or PCR instrument.
It is further contemplated that prior to performing the step, prior to sequencing the nucleic acid fragments identified in the sequence, connecting the adapter sequence to the nucleic acid fragments to be sequenced and sequencing the nucleic acid fragments to which the adapter is attached can do.
The step of connecting the adapter sequence may be a method using PCR assemble or a method using ligation. When connecting the adapter, a 15 to 30 bp bar code sequence can be added as needed.
In addition, after the base sequence analysis, the step of recovering the base sequence analysis plate may further include the step of recovering the base sequence analysis plate. At this time, do not perform the washing and bleaching steps as the last step of next-generation sequencing.
According to another embodiment of the present invention, there is provided a method for recovering a nucleic acid fragment using a method of shrinking a nucleic acid fragment library through super parallel sequencing. The method comprises the steps of: (a) preparing a sequencing plate with a DNA library; (b) providing a scaled down nucleic acid fragment library sequenced through hyperparallel sequencing of said DNA library; (c) positioning the sequencing plate with all of the sequence-identified nucleic acid fragments in an amplifier; (d) amplifying the entire nucleic acid fragments located in the amplifier; And (e) recovering the amplified nucleic acid fragments.
In a preferred embodiment, if necessary, (f) recovering the desired nucleic acid fragments from the recovered nucleic acid fragments may be further included.
The process of shrinking the DNA library through the superparallel sequencing can be described as follows. For example, a DNA library containing nucleic acid fragments of several hundreds of millions to several hundreds of millions is analyzed using Roche-454 GS Junior. First, during the sequencing preparation, the concentration of the first DNA library is measured, and the number of molecules is calculated and diluted. At this time, about 5 to 20 x 10 6 nucleic acid fragments are reacted with about 10 7 sequencing beads to carry out emulsion PCR. Then, sequencing beads with nucleic acid fragments amplified by immersion PCR are collected, washed and bead enrichment is carried out, and sequencing is performed by injecting into a sequencing plate. Among these, the number of sequencing readings obtained by successful sequencing is about 50,000 to 100,000, so that the number of nucleic acid fragments becomes smaller than that of the original DNA library. For example, when analyzing a DNA library containing hundreds of millions to several tens of millions of nucleic acid fragments using Ion-Torrent Proton, the nucleic acid fragments of about 7 to 10 × 10 11 , After mixing with the beads for sequencing, emulsion PCR allows only one kind of nucleic acid fragments to form double stranded nucleic acid in one kind of beads. In order to enable sequencing through the enrichment process, only about 3 to 5 x 10 11 (half of the total) nucleic acid fragments remain when the nucleic acid fragments having different adapter sequences are separated from each other. Among these, the number of sequencing readings obtained by successful sequencing is about 60 to 80 million, so that the number of nucleic acid fragments becomes smaller than that of the original DNA library.
According to the present inventors' method, since the DNA library of the entire DNA library is analyzed by the next-generation sequencing method, the size of the DNA library is effectively reduced by the number of the next generation sequencing analysis readings . The analyzed sequencing plate can be placed in a sealed chamber and recovered from the sequencing plate by amplifying the reduced DNA library. In addition, when the DNA library contains a bar code sequence, the desired nucleic acid fragment can be obtained from the reduced DNA library at a higher recovery rate.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, preferred embodiments of a sealing chamber according to the present invention will be described with reference to the accompanying drawings. The present embodiments are not intended to be limiting.
Spatially relative terms such as "bottom "," top ", and the like can be used to easily describe one member or components and other members or components as shown in the figures. Spatially relative terms should be understood to include, in addition to the orientation shown in the drawings, terms that include different orientations of the device during use or operation. For example, when changing the viewpoint by changing the orientation of a member shown in the drawing, a portion described as "side" can constitute a "front portion ". Thus, the exemplary term "side" may include both forward and backward directions outside the side. The members can also be oriented in different directions, so that spatially relative terms can be interpreted according to orientation.
The thickness and size of each member in the drawings are exaggerated, omitted, or schematically shown for convenience and clarity of explanation. Also, the size and area of each component do not entirely reflect actual size or area.
FIG. 5 is a perspective view of a sealing chamber according to an embodiment of the present invention, and FIG. 6 is an exploded view of a sealing chamber according to an embodiment of the present invention. FIG. 7 is a plan view of a sealing chamber according to an embodiment of the present invention, FIG. 8 is a sectional view taken along line A-A of FIG. 7, and FIG. 9 is a sectional view taken along line B-B of FIG.
5 and 6, a sealing
A predetermined
The
The
The sample
On the other hand, preferably, the
The
The
A
The
For example, the
5 and 6 illustrate that one
The pressurizing
The
6, the
The
A
According to a preferred embodiment of the present invention, a predetermined first concave-convex portion is formed on the upper surface and the lower surface of the
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, It should be understood that various modifications may be made by those skilled in the art without departing from the spirit and scope of the invention.
Hereinafter, the present invention will be described in more detail with reference to the following examples and test examples, but the present invention is not limited to the following examples and test examples.
Production Example 1. Production of Sealing Chamber
A sealing chamber for mounting a plate for next-generation nucleotide sequence analysis was prepared. The sealing chamber was made of metal with a good thermal conductivity and was designed to use a rubber cover so that the PCR solution between the sealing chamber and the plate was sealed when the plate for the next generation sequencing was sealed without leakage. Also make sure that the side of the cover is exposed on the side of the gasket.
A sealing chamber (not shown) including the
Example 1. Sequencing of a gene
Prior to sequencing the acquired DNA library, the process involved linking the adapter sequences proposed in the next generation sequencing. At this time, as a method of connecting the adapter sequence, a method using PCR assemble or a method using ligation was used. In addition, a 20 bp bar code sequence was added, and the length of the bar code sequence was adjustable.
When the adapter sequence is ligated using PCR assemble, the composition of the PCR solution is as follows. 10 μl of 2X Pfu polymerase master mix, 1 μl of 10 μM adapter for primer, 1 μl of 10 μM adapter rev primer, 5 μl of dw. The Pfu polymerase master mix used in the experiments was a 2X Pfu polymerase premix product sold by Solgent. Also, the primers used in the experiment include the 454 adapter sequence - the bar code sequence - the complementary sequence to the end sequence of the DNA library, and the actual sequence of the primer is as follows (adaptation forward primer (SEQ ID NO: 1): CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNNNNNNNNNNNNNNNNNACGTACGACAGAGTACTCGT, adapter reverse primer (SEQ ID NO: 2): CCTATCCCCTGTGTGCCTTGGCAGTCTCAGNNNNNNNNNNNNNNNNNNNNTCGAACTAATCGGATTGCG). At this time, the DNA denaturation was maintained at 95 ° C. for 10 minutes, and then 95 ° C., 30 seconds, 58 ° C., 30 seconds, 72 ° C. and 45 seconds were performed 15 times to 20 times, , And maintained for 10 minutes. The DNA library to which the adapter was connected was sequenced by Sanger sequencing method to confirm the connection.
(SEQ ID NO: 3)
(SEQ ID NO: 4)
(SEQ ID NO: 5)
(SEQ ID NO: 6)
(SEQ ID NO: 7)
(SEQ ID NO: 8)
(SEQ ID NO: 9)
(SEQ ID NO: 10)
Example 2. Increase of sequenced product
A sequencing plate, which was sequenced in the biofilm system in Example 1, was mounted and sealed in the sealing chamber produced in Production Example 1. The PCR solution was then injected using a syringe through the side of the rubber lid exposed on the side of the encapsulation chamber. At this time, the PCR solution contained DNA polymerase, dNTP, a primer containing the adapter sequence proposed in the next generation sequencing, a buffer or a corresponding PCR solution master mix.
The composition of the PCR solution is as follows. 600 μl of 2X Pfu polymerase master mix, 15 μl of 100 μM primer, 585 μl of dw. Amplification and extension of the nucleic acid fragments were performed by injecting the sealed chamber into which the PCR solution was injected into a water bath. The Pfu polymerase master mix used in the experiments was a 2X Pfu polymerase premix product sold by Solgent. The primer sequence used in the experiment was the 454 For sequence of the 454 adapter sequence (CCATCTCATCCCTGCGTGTCTCCGACTCAG: SEQ ID NO: 11). For the initial DNA denaturation, the cells were maintained at 95 ° C. for 10 minutes, followed by 95 ° C., 5 minutes, 60 ° C., 5 minutes and 72 ° C. for 5 minutes for 3 to 10 times, Lt; 0 > C for 10 minutes.
Example 3. Identification of amplified products
The sealed chamber was removed from the water bath and the PCR solution and amplified and extended nucleic acid fragments were recovered through the side of the rubber lid exposed on the side of the sealing chamber using a syringe. In this way, a DNA library having undergone the sequencing was recovered. This means that the entire DNA library has been reduced to the number of readings of next-generation sequencing.
The recovered and reduced DNA library was selectively amplified by a primer containing the bar code sequence to which it was linked. The amplified individual nucleic acid fragments completed the analysis of the nucleotide sequence through Sanger sequencing and showed a much improved recovery rate compared to the conventional method of collecting individual nucleic acid fragments ('Shotgun DNA synthesis' for the high- According to Kim et al., the efficiency of recovering individual nucleic acid fragments from the entire DNA library is about 77%, but 100% recovery is possible with the present invention, according to the throughput construction of large DNA molecules, 2012 Nucleic Acids Research, Kim et al.
The present invention reduces overall DNA library through sequencing to increase recovery of final target nucleic acid fragments. In addition, it provides a method that can more effectively utilize nucleic acid fragments that have not been used differently after sequencing. In addition, an amplifier capable of amplifying the nucleic acid fragments identified by the parallel synthesis is provided, and the amplified nucleic acid fragments can be rapidly amplified when amplified using such an amplifier, It can be effectively processed and thus it is considered to be an industrially useful invention.
1: sealing chamber 100: base chamber
110: storage chamber 120: guide part
130: mounting part 200: upper chamber
210: main body 220: pressing piece
222: fixing groove 230: storage groove
240: connection hole 250: fixing member
260: mounting part 300: sample receiving part
310: accommodation space 400: gasket
410: Hall 500: Jig
510: Support part 520: Extension part
530: screw hole 600: pressing portion
610: threaded portion 620: head
<110> University-Industry Foundation <120> Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments <130> P0530STN <160> 11 <170> Kopatentin 2.0 <210> 1 <211> 70 <212> DNA <213> Artificial Sequence <220> <223> adapter forward primer <400> 1 ccatctcatc cctgcgtgtc tccgactcag nnnnnnnnnn nnnnnnnnnn acgtacgaca 60 gagtactcgt 70 <210> 2 <211> 69 <212> DNA <213> Artificial Sequence <220> <223> adapter reverse primer <400> 2 cctatcccct gtgtgccttg gcagtctcag nnnnnnnnnn nnnnnnnnnn tcgaactaat 60 cggattgcg 69 <210> 3 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F1_1 <400> 3 ctcttctccg ccgcaaaatc tggcaactga aagagctggg ttatgcagcc gtggatgatg 60 aaaccacgca acagacaatg cgtgagttaa aagaactggg ctacacttcg gagccgcacg 120 ctgccgtagc ttatcgtgcg ctgcgtgatc agttgaatcc aggcgaatat ggcttgttcc 180 tcggcaccgc gcatccggcg aaatttaaag agagcgtgga agcgattctc ggtgaaacgt 240 tggatctgcc aaaagagctg gcagaacgtg ctgatttacc cttgctttca cataatctgc 300 ccgccgattt tgagagacc 319 <210> 4 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F1_2 <400> 4 ctcttctctt gaaggcaccg atacgctggc gtataccgat gcgcagtatc aacagcttgc 60 ggcggttacg cgcgcactga ttgattgcta tccggatatc gctaaaaaca tgacgggcca 120 ttgtgatatt gcgccggatc gcaaaaccga tcccggtcct gcatttgatt gggcacgctt 180 tcgtgtgctg gtcagcaagg agacaacatg acgctattta caaccttact ggtgttaatt 240 ttcgagcgcc tgtttaagtt gggcgagcac tggcagcttg atcatcgtct tgaagcgttc 300 tttcgccgcg tgagagacc 319 <210> 5 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F1_3 <400> 5 ctcttctgcc gccgactcaa acacctcgtc cgtcacctcc atcccgccgt gcagatcgaa 60 ctccttcgcc atctgcttgc cgagcgtagt ctggtcgtca tggaacgccg gcagacagtg 120 caggaacttc acgttcgggt tgtcggtcag cgccatcatc tgcgcgttca cctgataccc 180 gcgcagcagc gcaatgcgct ctgcccactt ctctttggcc tcgcccatcg acacccacac 240 gtcggtatag ataaagtccg cgcccttaac gcctgccgcc acgtcttccg tcagagtaat 300 tttcccgccg tgagagacc 319 <210> 6 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F2_1 <400> 6 ctcttctgcg ggtaaccacg ccctggcgaa tgtgttctac cagcggcgca tggcaatcac 60 tcagcgagct cgacgccagg gtcaggtttt taaagcccat cttcgcgatg acgtccatca 120 ccatattgac ggtcaggtca ccgccacgga aagcgtgatg gaacgaaacc gtcatgccgt 180 cctgtaaacc tgagcgacga atcgcttctt ccaggttggc gcacagtttg cgatcgcgcg 240 ctttttcagc ctggtaggtt tgctttggcg agttctggaa agcggcaaga tcgcattcag 300 cgcgacgatt ccagagacc 319 <210> 7 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F2_2 <400> 7 ctcttctagc tggataactt ccgtcaggaa gttcacggca atggcctctc atcgtatccg 60 cacccgaaac tgatgccgga attctggcag ttcccgaccg tatcaatggg tctgggtccg 120 attggtgcta tttaccaggc taaattcctg aaatatctgg aacaccgtgg cctgaaagat 180 acctcaaaac aaaccgttta cgcgttcctc ggtgacggtg aaatggacga accggaatcg 240 aaaggtgcga tcaccatcgc tacccgtgaa aaactggata acctggtctt cgttatcaac 300 tgtaacctgc agagagacc 319 <210> 8 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F3_1 <400> 8 ctcttctccc ggcgttgatg gcgtgaacaa aacaatgcta caggcccgtc tggctgttga 60 gctgcaaatc ctccgtgatg aattactctc aggccactac cagcccttgc ccgcccgtcg 120 cgtttacatc cctaaaagca acggcaaact gcgcccactg ggtatccccg cgttgcgcga 180 tcgtattgtt cagcgcgcca tgctgatggc gatggagccg atttgggaga gtgattttca 240 tacgctctca tatggcttcc gccctgagcg cagtgtccac cacgcgatcc gcacggtgaa 300 attacagctc acagagacc 319 <210> 9 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F3_2 <400> 9 ctcttctaac gcctgccgcc acgtcttccg tcagagtaat tttcccgccg tgcttctccg 60 ccagcgcgct gcactccgcc accaggctct cttccggcca gcaggctttc ggggccaaca 120 ggcgcagatc cagcccggtc agcgccgccg cttccagcat cgagttgccc atgttgttgc 180 gcgcatcgcc cgcgtagacc agcgtcatct cgttaaacgc cttgcccggc aggtgctcct 240 gcatggtcat caggtccgcc agcagctggg tcgggtggaa ctcgttggtc agcccgttcc 300 acaccggcac gcagagacc 319 <210> 10 <211> 319 <212> DNA <213> Artificial Sequence <220> <223> sequencing product F4_1 <400> 10 ctcttctcag tgcgagttcc ggctgaccag gaatgtaacg ttgcgcatgc agccaccagt 60 agagggcatt gcttcccagt ccacgttttt ctgcctgttg tagccagcga tcgcgagccg 120 caccatttcc tgccgcctgg gcggtattgg cagcagcaag cagatcctca ttgctcatgt 180 cgtgaagact gattttctgc caggccgcca gtgcggtggc gtagtcctca acctgatacg 240 cctgataggc taccgcacga tgttgccagg cgctcggttg gcgttgttcg gcctgaagcc 300 atgcatacaa cgagagacc 319 <210> 11 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> 454 Forward sequence <400> 11 ccatctcatc cctgcgtgtc tccgactcag 30
Claims (22)
(b) amplifying the sequence-confirmed nucleic acid fragments; And
(c) recovering said amplified nucleic acid fragments,
Wherein the step (a) is performed by placing the sequencing plate in which the sequence-confirmed nucleic acid fragments are present in the amplifier in the state after completion of the sequence confirmation.
(d) recovering the desired nucleic acid fragments from the recovered nucleic acid fragments.
Wherein the sequencing is performed by a method of synthesizing nucleic acid fragments.
Wherein the synthetic method is a Sanger method or a super parallel method.
Wherein the hyperparallel method is selected from the group consisting of pyrosequencing chemistry, bridge amplification, next generation sequencing, third generation sequencing, next generation sequencing, and semiconductor sequencing.
Wherein the amplifier is a sealed chamber in which a predetermined sample is received and sealed.
Further comprising injecting a polymerase, dNTP, or DNA polymerase solution into the amplifier for amplification of the nucleic acid fragment.
Wherein the recovery of the desired nucleic acid fragments is carried out using the beads when the amplified nucleic acid fragments are bound to the beads.
Wherein the recovery of the desired nucleic acid fragments is recovered using a sequence homologous to the barcode sequence when a specific barcode sequence is linked to the amplified nucleic acid fragments.
(b) sequencing nucleic acid fragments to which said adapter is attached;
(c) positioning said sequence-identified nucleic acid fragments in an amplifier;
(d) amplifying the sequence-confirmed nucleic acid fragments; And
(e) recovering the amplified nucleic acid fragments.
Wherein the step of connecting the adapter sequence is a method using PCR assemble or a method using ligation.
(b) providing a scaled down nucleic acid fragment library sequenced through hyperparallel sequencing of said DNA library;
(c) positioning the sequencing plate with the sequence-identified reduced nucleic acid fragment library in an amplifier;
(d) amplifying the entire nucleic acid fragments in the library located in the amplifier; And
(e) recovering the amplified nucleic acid fragments.
(f) recovering the desired nucleic acid fragments from the recovered nucleic acid fragments.
A base chamber capable of receiving a sequencing plate having the nucleic acid fragments;
An upper chamber which is engageable with and detachable from the base chamber and has a sealing structure as a whole when engaged with the base chamber; And
And an elastic gasket disposed between the base chamber and the upper chamber for sealing,
An inner space in which the PCR solution for amplifying the nucleic acid fragments is accommodated is formed by the coupling of the base chamber and the upper chamber,
Wherein at least one of the base chamber and the upper chamber is made of a material having thermal conductivity.
A base chamber in which a storage chamber is formed;
An upper chamber disposed on the base chamber;
A sample accommodating portion accommodated in the accommodating chamber and having a receiving space for accommodating a sample for amplifying the nucleic acid fragments;
A gasket disposed between the base chamber and the upper chamber and having elasticity;
A jig having a threaded hole connected to the base chamber and extending to an upper portion of the upper chamber, the threaded hole having an internally threaded portion; And
And a pressing part screwed to the screw hole,
Wherein the pressing portion includes a screw portion having a male screw portion and a head disposed on the screw portion,
Wherein the pressing of the upper chamber by the pressing portion is achieved as the head is pivoted to displace the pressing portion with respect to the jig.
The jig,
A U-shaped support portion bent on both sides facing each other, and
And a predetermined extension portion connecting the upper portion of the support portion,
The screw hole is formed in the extended portion,
And the base chamber and the upper chamber are supported by the support portion.
Wherein the base chamber comprises:
And a guide portion for allowing the gasket and the upper chamber to be fixed in position.
The upper chamber includes:
The body portion,
A pressing piece which is pressed in contact with the pressing portion, and
And a housing groove formed in the main body portion and accommodating the pressing piece.
The upper chamber includes:
A connection hole formed at a side of the main body and connected to the receiving groove,
A fixing groove formed on a side of the pressing piece,
And a fixing member connected to the connection groove through the connection hole.
A predetermined first irregular portion is formed on an upper surface and a lower surface of the gasket in contact with the base chamber and the upper chamber,
And a second concavo-convex portion corresponding to the first concavo-convex portion is formed on an upper surface of the base chamber and a lower surface of the upper chamber, which contact the gasket.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130070660A KR101576709B1 (en) | 2013-06-19 | 2013-06-19 | Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments |
PCT/KR2014/005439 WO2014204246A1 (en) | 2013-06-19 | 2014-06-19 | Method for retrieving sequence-verified nucleic acid fragments and apparatus for amplifying sequence-verified nucleic acid fragments |
US14/975,873 US10526640B2 (en) | 2013-06-19 | 2015-12-21 | Methods for retrieving sequence-verified nucleic acid fragments and apparatuses for amplifying sequence verified nucleic acid fragments |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130070660A KR101576709B1 (en) | 2013-06-19 | 2013-06-19 | Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140147429A KR20140147429A (en) | 2014-12-30 |
KR101576709B1 true KR101576709B1 (en) | 2015-12-10 |
Family
ID=52104901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130070660A KR101576709B1 (en) | 2013-06-19 | 2013-06-19 | Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101576709B1 (en) |
WO (1) | WO2014204246A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020017212A (en) * | 2000-08-29 | 2002-03-07 | 장기영 | Thermal cycler |
JP5570422B2 (en) * | 2009-01-16 | 2014-08-13 | アークレイ株式会社 | Nucleic acid sample production method and nucleic acid amplification product production method using the same |
KR20110108177A (en) * | 2010-03-26 | 2011-10-05 | 삼성전자주식회사 | Method for preparing target nucleic acid |
US9340826B2 (en) * | 2011-08-01 | 2016-05-17 | Celemics, Inc. | Method of preparing nucleic acid molecules |
-
2013
- 2013-06-19 KR KR1020130070660A patent/KR101576709B1/en not_active IP Right Cessation
-
2014
- 2014-06-19 WO PCT/KR2014/005439 patent/WO2014204246A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR20140147429A (en) | 2014-12-30 |
WO2014204246A1 (en) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2749653A1 (en) | Molecular coding for analysis of composition of macromolecules and molecular complexes | |
EP3826762A1 (en) | Massively parallel enzymatic synthesis of nucleic acid strands | |
US20130344540A1 (en) | Methods for minimizing sequence specific bias | |
US20150232921A1 (en) | Method for detecting nucleic acid | |
US9322063B2 (en) | Efficient biomolecule recycling method and system | |
CN105899682A (en) | Duplicating DNA with contiguity barcodes for genome and epigenome sequencing | |
KR101576709B1 (en) | Method of collecting sequence-verified nucleic acid fragments and the equipment for amplifying sequence-verified nucleic acid fragments | |
CN114555821B (en) | Detection of sequences uniquely associated with a target region of DNA | |
US20190040461A1 (en) | Method for extracting and characterizing molecular clones | |
US11959074B2 (en) | System and method for automated repeat sequencing | |
KR101648252B1 (en) | Method of collecting nucleic acid fragments separated from the sequencing process | |
CN114181934A (en) | Extraction method of sheep blood genome DNA (deoxyribonucleic acid), application of extraction method and genetic diversity evaluation method of sheep resource population | |
US20220170093A1 (en) | System and method for sequencing | |
CN107674920B (en) | Chimeric multiplex PCR primer composition and detection method | |
US10526640B2 (en) | Methods for retrieving sequence-verified nucleic acid fragments and apparatuses for amplifying sequence verified nucleic acid fragments | |
CN211142050U (en) | Trace cell nucleic acid extraction and amplification system | |
EP3209420A1 (en) | Nucleic acid amplification apparatus and system | |
US20120071327A1 (en) | Indexing of nucleic acid populations | |
Edwards | Whole-genome sequencing for marker discovery | |
KR20090028894A (en) | Method for identification korean cattle using multiplex pcr | |
CN102787160A (en) | Method for high throughput detection of gene polymorphism | |
RU2021133017A (en) | METHOD AND COMPOSITION FOR ANALYSIS OF CELLULAR COMPONENTS | |
Webster et al. | Whole genome amplification and exome sequencing of archived schistosome miracidia | |
US20220162685A1 (en) | Method for analyzing cell sample heterogeneity | |
Boopathi et al. | Toward Genetically Improved Crop Plants: Roles of ‘Omics in MAS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |